Implantable Cardioverter–Defibrillator Therapies Following Generator Replacements—Long-Term Remote Monitoring Data

<b>Background</b>: The rate of long-term outcomes, including arrhythmic episodes following implantable cardioverter-defibrillator (ICD) device replacements, is often unknown. Thus, the aim of this manuscript was to evaluate the risk of ICD or cardiac resynchronization therapy-defibrillator (CRT-D) therapies in remotely monitored patients following device replacement. <b>Methods</b>: Data from 134 patients who underwent ICD/CRT-D replacement or upgrade were analyzed. Kaplan-Meier estimates, as well as Cox proportional hazards regression, were used to present long-term outcomes and predictors of study endpoints, these being all-cause mortality, and appropriate and inappropriate ICD/CRT-D therapies. <b>Results</b>: Among the cohort, 51.5% of patients received ICDs and 48.5% received CRT-Ds; the median (quartile 1-quartile 3) LVEF at replacement was 23.0% (18.0-28.0%). In 11 (8.2%) patients, the LVEF at replacement was higher than 35%. During the median (Q1-Q3) follow-up of 3.0 (1.4-5.0) years, 32.1% experienced appropriate and 6.0% experienced inappropriate therapies. The all-cause mortality rate was 38.0%, and appropriate antitachycardia pacing (ATP), a reduced baseline LVEF, and no history of myocardial infarction were independent predictors of death (odds ratios of 1.87 for appropriate ATP, 0.88 per 1% of the LVEF and 0.54 for a history of MI, respectively). The rate of appropriate device therapies was numerically lower in patients whose LVEF improved (19.8% vs. 33.3% and 0% vs. 6.5%, for appropriate and inappropriate therapies). An LVEF of >35% at replacement did not influence the analyzed outcomes. <b>Conclusions</b>: In patients who underwent ICD/CRT-D replacement, an improvement in LVEF was not identified as either a predictor of improved survival or of a lower risk of needing device therapies. Further stratification models are needed to evaluate the arrhythmic risk in patients after generator replacements.

Authors

Institutions

Publication Details

Journal
Clinics and Practice
Published
2025-08-30
DOI
https://doi.org/10.3390/clinpract15090160
Primary Topic
Cardiac pacing and defibrillation studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Implantable Cardioverter–Defibrillator Therapies Following Generator Replacements—Long-Term Remote Monitoring Data

Elżbieta Adamowicz‐Czoch, Anna Kurek, Joanna Machowicz, Mariusz Gąsior et al.
Clinics and Practice
Cardiac pacing and defibrillation studies
article

Implantable Cardioverter–Defibrillator Therapies Following Generator Replacements—Long-Term Remote Monitoring Data

Elżbieta Adamowicz‐Czoch, Anna Kurek, Joanna Machowicz, Mariusz Gąsior, Jacek Niedziela, Maciej Dyrbuś, Michał Skrzypek, Łukasz Pyka, Mateusz Ostręga, Katarzyna Sokoła, Mateusz Tajstra, Damian Pres
article en

Abstract

<b>Background</b>: The rate of long-term outcomes, including arrhythmic episodes following implantable cardioverter-defibrillator (ICD) device replacements, is often unknown. Thus, the aim of this manuscript was to evaluate the risk of ICD or cardiac resynchronization therapy-defibrillator (CRT-D) therapies in remotely monitored patients following device replacement. <b>Methods</b>: Data from 134 patients who underwent ICD/CRT-D replacement or upgrade were analyzed. Kaplan-Meier estimates, as well as Cox proportional hazards regression, were used to present long-term outcomes and predictors of study endpoints, these being all-cause mortality, and appropriate and inappropriate ICD/CRT-D therapies. <b>Results</b>: Among the cohort, 51.5% of patients received ICDs and 48.5% received CRT-Ds; the median (quartile 1-quartile 3) LVEF at replacement was 23.0% (18.0-28.0%). In 11 (8.2%) patients, the LVEF at replacement was higher than 35%. During the median (Q1-Q3) follow-up of 3.0 (1.4-5.0) years, 32.1% experienced appropriate and 6.0% experienced inappropriate therapies. The all-cause mortality rate was 38.0%, and appropriate antitachycardia pacing (ATP), a reduced baseline LVEF, and no history of myocardial infarction were independent predictors of death (odds ratios of 1.87 for appropriate ATP, 0.88 per 1% of the LVEF and 0.54 for a history of MI, respectively). The rate of appropriate device therapies was numerically lower in patients whose LVEF improved (19.8% vs. 33.3% and 0% vs. 6.5%, for appropriate and inappropriate therapies). An LVEF of >35% at replacement did not influence the analyzed outcomes. <b>Conclusions</b>: In patients who underwent ICD/CRT-D replacement, an improvement in LVEF was not identified as either a predictor of improved survival or of a lower risk of needing device therapies. Further stratification models are needed to evaluate the arrhythmic risk in patients after generator replacements.

Clinics and PracticeVol. 15(9)
Medical University of Silesia (PL), Wojewódzki Szpital Specjalistyczny nr 4 w Bytomiu (PL)
Openalex Percentile: Top 64%
Cardiac pacing and defibrillation studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.